Hesperidin inhibits the epithelial to mesenchymal transition induced by transforming growth factor-β1 in A549 cells through Smad signaling in the cytoplasm

Hesperidin, a natural compound, suppresses the epithelial-to-mesenchymal transition through the TGF-β1/Smad signaling pathway. However, studies on the detailed effects and mechanisms of hesperidin are rare. The present study showed that, for A549 alveolar epithelial cells, the anti-proliferative eff...

Full description

Bibliographic Details
Main Authors: Zhouxin Ren, Junling Shen, Xiaofeng Mei, Haoran Dong, Jiansheng Li, Haibin Yu
Format: Article
Language:English
Published: Universidade de São Paulo 2019-10-01
Series:Brazilian Journal of Pharmaceutical Sciences
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502019000100566&tlng=en
_version_ 1818340285385539584
author Zhouxin Ren
Junling Shen
Xiaofeng Mei
Haoran Dong
Jiansheng Li
Haibin Yu
author_facet Zhouxin Ren
Junling Shen
Xiaofeng Mei
Haoran Dong
Jiansheng Li
Haibin Yu
author_sort Zhouxin Ren
collection DOAJ
description Hesperidin, a natural compound, suppresses the epithelial-to-mesenchymal transition through the TGF-β1/Smad signaling pathway. However, studies on the detailed effects and mechanisms of hesperidin are rare. The present study showed that, for A549 alveolar epithelial cells, the anti-proliferative effects of hesperidin occurred in a dose-dependent manner, with an IC50= 216.8 µM at 48 h. TGF-β1 was used to activate the Smad signaling pathway and induce the epithelial to mesenchymal transition in cells. Treatment with hesperidin or SB431542 was used for antagonism of Smad pathway activation. Hesperidin inhibited the increase in ɑ-SMA and Col1ɑ-1 and the decrease in E-cadherin in a dose-dependent manner from concentration of 20 µM to 60 µM, as assessed by both ELISA and Western blotting assays; however, there was no significant effect on cellular morphological alterations. Moreover, the Western blotting assay showed that, in the cytoplasm, hesperidin and SB431542 had no significant effect on the protein expression of Smad 2, 3, 4, or 7 as well as 2/3. However, 60 µM hesperidin and SB431542 significantly decreased p-Smad2/3 protein expression. From the above results, it is concluded that hesperidin can partly inhibit the epithelial to mesenchymal transition in human alveolar epithelial cells; the effect accounts for the blockage of the phosphorylation of Smad2/3 in the cytoplasm rather than a change in Smad protein production in the cytoplasm.
first_indexed 2024-12-13T15:40:28Z
format Article
id doaj.art-385304b719694b50b76bf66292eb8986
institution Directory Open Access Journal
issn 2175-9790
language English
last_indexed 2024-12-13T15:40:28Z
publishDate 2019-10-01
publisher Universidade de São Paulo
record_format Article
series Brazilian Journal of Pharmaceutical Sciences
spelling doaj.art-385304b719694b50b76bf66292eb89862022-12-21T23:39:50ZengUniversidade de São PauloBrazilian Journal of Pharmaceutical Sciences2175-97902019-10-015510.1590/s2175-97902019000218172Hesperidin inhibits the epithelial to mesenchymal transition induced by transforming growth factor-β1 in A549 cells through Smad signaling in the cytoplasmZhouxin Renhttps://orcid.org/0000-0002-3212-9656Junling ShenXiaofeng MeiHaoran Donghttps://orcid.org/0000-0003-4437-2060Jiansheng LiHaibin YuHesperidin, a natural compound, suppresses the epithelial-to-mesenchymal transition through the TGF-β1/Smad signaling pathway. However, studies on the detailed effects and mechanisms of hesperidin are rare. The present study showed that, for A549 alveolar epithelial cells, the anti-proliferative effects of hesperidin occurred in a dose-dependent manner, with an IC50= 216.8 µM at 48 h. TGF-β1 was used to activate the Smad signaling pathway and induce the epithelial to mesenchymal transition in cells. Treatment with hesperidin or SB431542 was used for antagonism of Smad pathway activation. Hesperidin inhibited the increase in ɑ-SMA and Col1ɑ-1 and the decrease in E-cadherin in a dose-dependent manner from concentration of 20 µM to 60 µM, as assessed by both ELISA and Western blotting assays; however, there was no significant effect on cellular morphological alterations. Moreover, the Western blotting assay showed that, in the cytoplasm, hesperidin and SB431542 had no significant effect on the protein expression of Smad 2, 3, 4, or 7 as well as 2/3. However, 60 µM hesperidin and SB431542 significantly decreased p-Smad2/3 protein expression. From the above results, it is concluded that hesperidin can partly inhibit the epithelial to mesenchymal transition in human alveolar epithelial cells; the effect accounts for the blockage of the phosphorylation of Smad2/3 in the cytoplasm rather than a change in Smad protein production in the cytoplasm.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502019000100566&tlng=enHesperidinEpithelial-to-mesenchymal transition (EMT)Smad signaling pathwayInhibition
spellingShingle Zhouxin Ren
Junling Shen
Xiaofeng Mei
Haoran Dong
Jiansheng Li
Haibin Yu
Hesperidin inhibits the epithelial to mesenchymal transition induced by transforming growth factor-β1 in A549 cells through Smad signaling in the cytoplasm
Brazilian Journal of Pharmaceutical Sciences
Hesperidin
Epithelial-to-mesenchymal transition (EMT)
Smad signaling pathway
Inhibition
title Hesperidin inhibits the epithelial to mesenchymal transition induced by transforming growth factor-β1 in A549 cells through Smad signaling in the cytoplasm
title_full Hesperidin inhibits the epithelial to mesenchymal transition induced by transforming growth factor-β1 in A549 cells through Smad signaling in the cytoplasm
title_fullStr Hesperidin inhibits the epithelial to mesenchymal transition induced by transforming growth factor-β1 in A549 cells through Smad signaling in the cytoplasm
title_full_unstemmed Hesperidin inhibits the epithelial to mesenchymal transition induced by transforming growth factor-β1 in A549 cells through Smad signaling in the cytoplasm
title_short Hesperidin inhibits the epithelial to mesenchymal transition induced by transforming growth factor-β1 in A549 cells through Smad signaling in the cytoplasm
title_sort hesperidin inhibits the epithelial to mesenchymal transition induced by transforming growth factor β1 in a549 cells through smad signaling in the cytoplasm
topic Hesperidin
Epithelial-to-mesenchymal transition (EMT)
Smad signaling pathway
Inhibition
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502019000100566&tlng=en
work_keys_str_mv AT zhouxinren hesperidininhibitstheepithelialtomesenchymaltransitioninducedbytransforminggrowthfactorb1ina549cellsthroughsmadsignalinginthecytoplasm
AT junlingshen hesperidininhibitstheepithelialtomesenchymaltransitioninducedbytransforminggrowthfactorb1ina549cellsthroughsmadsignalinginthecytoplasm
AT xiaofengmei hesperidininhibitstheepithelialtomesenchymaltransitioninducedbytransforminggrowthfactorb1ina549cellsthroughsmadsignalinginthecytoplasm
AT haorandong hesperidininhibitstheepithelialtomesenchymaltransitioninducedbytransforminggrowthfactorb1ina549cellsthroughsmadsignalinginthecytoplasm
AT jianshengli hesperidininhibitstheepithelialtomesenchymaltransitioninducedbytransforminggrowthfactorb1ina549cellsthroughsmadsignalinginthecytoplasm
AT haibinyu hesperidininhibitstheepithelialtomesenchymaltransitioninducedbytransforminggrowthfactorb1ina549cellsthroughsmadsignalinginthecytoplasm